Cambia (Royalty Interest)
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
A pharmaceutical product indicated for the treatment of migraine. The drug provides migraine pain relief in 2 hours with effects starting within 15 minutes from consumption.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- United States
Cambia (Royalty Interest) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Cambia (Royalty Interest)‘s full profile, request access.
Request full access to PitchBook